Ptc Therapeutics, Inc. logo

PTCT

Ptc Therapeutics, Inc.

$37.69

Earnings Summary

Revenue
$210.12Mn
Net Profits
$-91.58Mn
Net Profit Margins
-43.58%

Highlights

Revenue:

Ptc Therapeutics, Inc.’s revenue fell -4.66% since last year same period to $210.12Mn in the Q1 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated -31.57% fall in its revenue since last 3-months.

Net Profits:

Ptc Therapeutics, Inc.’s net profit jumped 34.1% since last year same period to $-91.58Mn in the Q1 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 41.22% jump in its net profits since last 3-months.

Net Profit Margins:

Ptc Therapeutics, Inc.’s net profit margin jumped 30.88% since last year same period to -43.58% in the Q1 2024. On a quarterly growth basis, Ptc Therapeutics, Inc. has generated 14.1% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Ptc Therapeutics, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-1.07
EPS Estimate Current Year
-1.07

Highlights

EPS Estimate Current Quarter:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.07 - a 13.71% jump from last quarter’s estimates.

EPS Estimate Current Year:

Ptc Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -1.07.

Key Ratios

Key ratios of the Ptc Therapeutics, Inc. post its Q1 2024 earnings

Earning Per Share (EPS)
-1.2
Return on Assets (ROA)
-0.1
Return on Equity (ROE)
-77.4

Highlights

Earning Per Share (EPS):

Ptc Therapeutics, Inc.’s earning per share (EPS) jumped 36.17% since last year same period to -1.2 in the Q1 2024. This indicates that the Ptc Therapeutics, Inc. has generated 36.17% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Ptc Therapeutics, Inc.’s return on assets (ROA) stands at -0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Ptc Therapeutics, Inc.’s return on equity (ROE) stands at -77.4.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-04-25
-1.24
-1.2
3.23%